Literature DB >> 12515340

Laboratory security and emergency response guidance for laboratories working with select agents. Centers for Disease Control and Prevention.

Jonathan Y Richmond1, Shanna L Nesby-O'Dell.   

Abstract

In recent years, concern has increased regarding use of biologic materials as agents of terrorism, but these same agents are often necessary tools in clinical and research microbiology laboratories. Traditional biosafety guidelines for laboratories have emphasized use of optimal work practices, appropriate containment equipment, well-designed facilities, and administrative controls to minimize risk of worker injury and to ensure safeguards against laboratory contamination. The guidelines discussed in this report were first published in 1999 (U.S. Department of Health and Human Services/CDC and National Institutes of Health. Biosafety in microbiological and biomedical laboratories [BMBL]. Richmond JY, McKinney RW, eds. 4th ed. Washington, DC: US Department of Health and Human Services, 1999 [Appendix F]). In that report, physical security concerns were addressed, and efforts were focused on preventing unauthorized entry to laboratory areas and preventing unauthorized removal of dangerous biologic agents from the laboratory. Appendix F of BMBL is now being revised to include additional information regarding personnel risk assessments, and inventory controls. The guidelines contained in this report are intended for laboratories working with select agents under biosafety-level 2, 3, or 4 conditions as described in Sections II and III of BMBL. These recommendations include conducting facility risk assessments and developing comprehensive security plans to minimize the probability of misuse of select agents. Risk assessments should include systematic, site-specific reviews of 1) physical security; 2) security of data and electronic technology systems; 3) employee security; 4) access controls to laboratory and animal areas; 5) procedures for agent inventory and accountability; 6) shipping/transfer and receiving of select agents; 7) unintentional incident and injury policies; 8) emergency response plans; and 9) policies that address breaches in security. The security plan should be an integral part of daily operations. All employees should be well-trained and equipped, and the plan should be reviewed annually, at least.

Entities:  

Mesh:

Year:  2002        PMID: 12515340

Source DB:  PubMed          Journal:  MMWR Recomm Rep        ISSN: 1057-5987


  11 in total

1.  Retrospective investigation of an influenza A/H1N1pdm outbreak in an Italian military ship cruising in the Mediterranean Sea, May-September 2009.

Authors:  Mario Tarabbo; Daniele Lapa; Concetta Castilletti; Pietro Tommaselli; Riccardo Guarducci; Giuditta Lucà; Alessandro Emanuele; Onofrio Zaccaria; Vincenzo F P La Gioia; Enrico Girardi; Maria R Capobianchi; Giuseppe Ippolito
Journal:  PLoS One       Date:  2011-01-20       Impact factor: 3.240

2.  In vitro evolution of H5N1 avian influenza virus toward human-type receptor specificity.

Authors:  Li-Mei Chen; Ola Blixt; James Stevens; Aleksandr S Lipatov; Charles T Davis; Brian E Collins; Nancy J Cox; James C Paulson; Ruben O Donis
Journal:  Virology       Date:  2011-11-05       Impact factor: 3.616

3.  Prophylactic alpha interferon treatment increases the therapeutic index of oncolytic vesicular stomatitis virus virotherapy for advanced hepatocellular carcinoma in immune-competent rats.

Authors:  Katsunori Shinozaki; Oliver Ebert; Arief Suriawinata; Swan N Thung; Savio L C Woo
Journal:  J Virol       Date:  2005-11       Impact factor: 5.103

Review 4.  Coccidioidomycosis: host response and vaccine development.

Authors:  Rebecca A Cox; D Mitchell Magee
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

5.  Reassortment between avian H5N1 and human H3N2 influenza viruses in ferrets: a public health risk assessment.

Authors:  Sara Jackson; Neal Van Hoeven; Li-Mei Chen; Taronna R Maines; Nancy J Cox; Jacqueline M Katz; Ruben O Donis
Journal:  J Virol       Date:  2009-06-03       Impact factor: 5.103

6.  Monkeypox Virus Host Factor Screen Using Haploid Cells Identifies Essential Role of GARP Complex in Extracellular Virus Formation.

Authors:  Susan Realegeno; Andreas S Puschnik; Amrita Kumar; Cynthia Goldsmith; Jillybeth Burgado; Suryaprakash Sambhara; Victoria A Olson; Darin Carroll; Inger Damon; Tetsuya Hirata; Taroh Kinoshita; Jan E Carette; Panayampalli Subbian Satheshkumar
Journal:  J Virol       Date:  2017-05-12       Impact factor: 6.549

7.  Assessment of biosafety precautions in Khartoum state diagnostic laboratories, Sudan.

Authors:  Adel Hussein Elduma
Journal:  Pan Afr Med J       Date:  2012-02-03

8.  Challenges and Practices in Building and Implementing Biosafety and Biosecurity Programs to Enable Basic and Translational Research with Select Agents.

Authors:  Colleen B Jonsson; Kelly Stefano Cole; Chad J Roy; David S Perlin; Gerald Byrne
Journal:  J Bioterror Biodef       Date:  2013-04-29

9.  Cross-subtype immunity against avian influenza in persons recently vaccinated for influenza.

Authors:  Cristiana Gioia; Concetta Castilletti; Massimo Tempestilli; Paola Piacentini; Licia Bordi; Roberta Chiappini; Chiara Agrati; Salvatore Squarcione; Giuseppe Ippolito; Vincenzo Puro; Maria R Capobianchi; Fabrizio Poccia
Journal:  Emerg Infect Dis       Date:  2008-01       Impact factor: 6.883

10.  Air sampling to assess potential generation of aerosolized viable bacteria during flow cytometric analysis of unfixed bacterial suspensions.

Authors:  Christine F Carson; Timothy Jj Inglis
Journal:  Gates Open Res       Date:  2018-02-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.